BPH With Urinary Obstruction
14
5
5
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.1%
1 terminated out of 14 trials
80.0%
-6.5% vs benchmark
21%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
Randomized Controlled Trial of Different Antibiotic Duration Prior to Prostate Enucleation Surgery
Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate
PUL vs TURP in BPH Patients With Urinary Retention
Readmission Following Prostatic Surgery
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL)
HoLEP vs BPRP in the Management of a Large Volume (> 80 gm) Symptomatic BPH
Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy
HoLEP vs BPRP of a Large Volume BPH: a Randomised Controlled Trial
Optimizing Pain Control in Transurethral Resection of the Prostate
Holmium Laser vs Bipolar Enucleation of a Large Volume BPH: a Randomised Controlled Study
Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT
Early Versus Late Catheter Removal in Patients With Acute Urinary Retention Secondary to BPH Under Tamsulosin Treatment